4.8 Review

The lung microbiome: progress and promise

期刊

JOURNAL OF CLINICAL INVESTIGATION
卷 131, 期 15, 页码 -

出版社

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI150473

关键词

-

资金

  1. NIH [R33-HL137063, KL2-TR001879]
  2. Cystic Fibrosis Foundation

向作者/读者索取更多资源

The healthy lung is not completely sterile, with bacteria entering from the upper respiratory tract through microaspiration. The nature and dynamics of the lung microbiome differ from other ecological niches with self-sustaining microbial communities, and dysbiosis has been demonstrated in many pulmonary diseases.
The healthy lung was long thought of as sterile, but recent advances using molecular sequencing approaches have detected bacteria at low levels. Healthy lung bacteria largely reflect communities present in the upper respiratory tract that enter the lung via microaspiration, which is balanced by mechanical and immune clearance and likely involves limited local replication. The nature and dynamics of the lung microbiome, therefore, differ from those of ecological niches with robust self-sustaining microbial communities. Aberrant populations (dysbiosis) have been demonstrated in many pulmonary diseases not traditionally considered microbial in origin, and potential pathways of microbe-host crosstalk are emerging. The question now is whether and how dysbiotic microbiota contribute to initiation or perpetuation of injury. The fungal microbiome and virome are less well studied. This Review highlights features of the lung microbiome, unique considerations in studying it, examples of dysbiosis in selected disease, emerging concepts in lung microbiome-host interactions, and critical areas for investigation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据